- Home
- TLSI vs ESEA Comparison
TLSI vs ESEA Comparison
Compare TLSI & ESEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- ESEA
- Stock Information
- Founded
- TLSI 2010
- ESEA 2005
- Country
- TLSI United States
- ESEA Greece
- Employees
- TLSI N/A
- ESEA N/A
- Industry
- TLSI Medical Specialities
- ESEA Marine Transportation
- Sector
- TLSI Health Care
- ESEA Consumer Discretionary
- Exchange
- TLSI Nasdaq
- ESEA Nasdaq
- Market Cap
- TLSI 204.0M
- ESEA 208.2M
- IPO Year
- TLSI N/A
- ESEA 2006
- Fundamental
- Price
- TLSI $4.56
- ESEA $51.77
- Analyst Decision
- TLSI Strong Buy
- ESEA Strong Buy
- Analyst Count
- TLSI 5
- ESEA 1
- Target Price
- TLSI $10.90
- ESEA $62.00
- AVG Volume (30 Days)
- TLSI 134.8K
- ESEA 42.8K
- Earning Date
- TLSI 08-13-2025
- ESEA 08-05-2025
- Dividend Yield
- TLSI N/A
- ESEA 5.01%
- EPS Growth
- TLSI N/A
- ESEA 21.86
- EPS
- TLSI N/A
- ESEA 18.62
- Revenue
- TLSI $32,141,000.00
- ESEA $222,525,034.00
- Revenue This Year
- TLSI $55.39
- ESEA $7.22
- Revenue Next Year
- TLSI $54.89
- ESEA $1.75
- P/E Ratio
- TLSI N/A
- ESEA $2.79
- Revenue Growth
- TLSI 46.20
- ESEA 14.62
- 52 Week Low
- TLSI $3.50
- ESEA $24.58
- 52 Week High
- TLSI $6.04
- ESEA $52.00
- Technical
- Relative Strength Index (RSI)
- TLSI 39.21
- ESEA 71.15
- Support Level
- TLSI $4.41
- ESEA $49.85
- Resistance Level
- TLSI $4.73
- ESEA $50.11
- Average True Range (ATR)
- TLSI 0.22
- ESEA 1.50
- MACD
- TLSI -0.02
- ESEA 0.06
- Stochastic Oscillator
- TLSI 18.99
- ESEA 95.66
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.